PROCEPT BioRobotics Corp financial data

Symbol
PRCT on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
150 Baytech Drive, San Jose, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Feb 27, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 773 % +0.79%
Quick Ratio 102 % -2.62%
Debt-to-equity 43.7 % -16.2%
Return On Equity -31.5 % +32.3%
Return On Assets -22 % +28.3%
Operating Margin -43 % +46.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 54.8M shares +6.6%
Common Stock, Shares, Outstanding 52.1M shares +3.32%
Entity Public Float 3.1B USD +121%
Common Stock, Value, Issued 0 USD
Weighted Average Number of Shares Outstanding, Basic 52.1M shares +10.3%
Weighted Average Number of Shares Outstanding, Diluted 52.1M shares +10.3%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 224M USD +64.8%
Cost of Revenue 87.4M USD +34.2%
Research and Development Expense 62.3M USD +28.6%
Operating Income (Loss) -96.6M USD +11.5%
Net Income (Loss) Attributable to Parent -91.4M USD +13.7%
Earnings Per Share, Basic -1.75 USD/shares +21.9%
Earnings Per Share, Diluted -1.75 USD/shares +21.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 334M USD +29.7%
Accounts Receivable, after Allowance for Credit Loss, Current 83.5M USD +72.6%
Inventory, Net 56.2M USD +41.3%
Assets, Current 482M USD +37.4%
Property, Plant and Equipment, Net 26.7M USD -7.09%
Operating Lease, Right-of-Use Asset 18.9M USD -6.42%
Other Assets, Noncurrent 2.56M USD +178%
Assets 534M USD +31.9%
Accounts Payable, Current 10M USD -25.7%
Contract with Customer, Liability, Current 9.57M USD +69.1%
Liabilities, Current 53.1M USD +15.7%
Contract with Customer, Liability, Noncurrent 517K USD
Operating Lease, Liability, Noncurrent 26.9M USD +2.62%
Other Liabilities, Noncurrent 324K USD -37.3%
Liabilities 132M USD +6.32%
Accumulated Other Comprehensive Income (Loss), Net of Tax 114K USD +35.7%
Retained Earnings (Accumulated Deficit) -546M USD -20.1%
Stockholders' Equity Attributable to Parent 402M USD +43.3%
Liabilities and Equity 534M USD +31.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -32.3M USD +10.1%
Net Cash Provided by (Used in) Financing Activities 2.59M USD +581%
Net Cash Provided by (Used in) Investing Activities -1.95M USD +63.6%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 52.1M shares +3.32%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -31.6M USD +22.6%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 337M USD +29.4%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1M USD -10.4%
Deferred Tax Assets, Valuation Allowance 156M USD +28.6%
Deferred Tax Assets, Gross 161M USD +27.2%
Operating Lease, Liability 28.8M USD +3.28%
Payments to Acquire Property, Plant, and Equipment 1.95M USD -63.6%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -91.4M USD +13.6%
Lessee, Operating Lease, Liability, to be Paid 40.8M USD -9.31%
Property, Plant and Equipment, Gross 34.5M USD +6.55%
Operating Lease, Liability, Current 1.91M USD +13.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 4.43M USD +3%
Lessee, Operating Lease, Liability, to be Paid, Year One 4.3M USD +2.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 12M USD -29.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three 4.81M USD +8.63%
Deferred Tax Assets, Operating Loss Carryforwards 96.5M USD +20.2%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 4.72M USD +39.1%
Lessee, Operating Lease, Liability, to be Paid, Year Four 4.95M USD +3%
Additional Paid in Capital 948M USD +29%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 1.18M USD +49.3%
Deferred Tax Assets, Net of Valuation Allowance 4.66M USD -6.09%
Share-based Payment Arrangement, Expense 31.8M USD +66.4%
Interest Expense 4.15M USD -10.6%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%